Home News Interviews Companies Videos Markets Subscribe

The Markets

Sort by Price Sort by Change ($)Sort by Change (%)

close X

Better Plant Sciences

close X

Champignon Brands

close X

Core One Labs Inc.

close X

Havn Life

close X

Mind Cure Health

close X

Mind Medicine (MindMed)

close X

Mydecine Innovations Group

close X

New Wave Holdings Corp

close X

Numinus

close X

Codebase Ventures

close X

EGF Theramed Health Corp

close X

Empower Clinics

close X

GreenStar Biosciences

close X

Hollister Biosciences

close X

Pharmadrug Inc.

close X

Red Light Holland

close X

Revive Therapeutics

close X

Thoughtful Brands Inc.

Features

COMPASS Pathways announces closing of initial public offering of American Depositary Shares and full exercise of underwriters’ option to purchase additional American Depositary Shares

News

MindMed Submits Application For NASDAQ Up-Listing, Appoints Canaccord Genuity As Financial Advisor

News

Mind Cure Announces Commencement of Trading on the CSE

News

Revive Therapeutics Provides Corporate Update on its Psychedelics Therapeutics Programs

GET THE HEADLINES + UPDATES

Be the first to see new company features, exclusive interviews and breaking news. Subscribe now.

Thanks for subscribing!

Oops! Something went wrong while submitting the form.

Numinus

Champignon Brands

Cybin Corp

Mind Medicine (MindMed)

Better Plant Sciences

NeonMind Biosciences Inc.

Mydecine Innovations Group

New Wave Holdings Corp

Hollister Biosciences

Gilgamesh Pharmaceuticals

Wake Network

Molecular Science Corp.

Empower Clinics

Anahit International Corp

MAPS

Orthogonal Thinker

Red Light Holland

GreenStar Biosciences

Thoughtful Brands Inc.

Lophora

2 3 5

Market Data copyright © 2020 QuoteMedia | Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges) | RT=Real-Time, EOD=End of Day, PD=Previous Day | Market Data powered by QuoteMedia | Terms of Use

Cookie Policy: We use cookies on this site to track usage and help improve the user experience. By continuing to use our site, you are agreeing to this policy.

Accept